论文部分内容阅读
目的:探讨孟鲁斯特联合雾化吸入治疗支气管哮喘的临床效果。方法:选取2011年6月-2014年12月我院内三科呼吸专业组接诊收治的160例支气管哮喘患者,随机分为两组,各组80例,对照组采用支气管扩张剂进行常规治疗,观察组采用孟鲁斯特联合雾化吸入进行治疗,观察两组治疗效果。结果:观察组治疗总有效率明显高于对照组,且PEF/FEV1两项肺功能指标改善程度优于对照组,无严重不良反应发生,整体效果优于对照组(P<0.05)。结论:孟鲁斯特联合雾化吸入治疗支气管哮喘疗效确切,安全性高,值得推广使用。
Objective: To investigate the clinical effect of combination of inhalation of Montelukast and bronchial asthma on bronchial asthma. Methods: A total of 160 patients with bronchial asthma admitted to our hospital from June 2011 to December 2014 were selected and randomly divided into two groups, 80 cases in each group. The control group was treated with bronchodilator routinely, The observation group was treated with inhalation of Montelukast combined with inhalation, and the therapeutic effect was observed in both groups. Results: The total effective rate of observation group was significantly higher than that of control group. The improvement of two indexes of pulmonary function of PEF / FEV1 was better than that of control group, without serious adverse reactions, the overall effect was better than that of control group (P <0.05). Conclusion: Montelukast inhalation combined with inhalation of bronchial asthma is effective, safe and worthy of promotion.